DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 75 filers reported holding DESIGN THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.8%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Cormorant Asset Management, LP | 5,364,850 | $78,810,000 | 3.20% |
Logos Global Management LP | 2,772,501 | $40,728,000 | 2.94% |
EcoR1 Capital, LLC | 1,863,098 | $27,369,000 | 0.95% |
RA Capital Management | 2,186,636 | $32,122,000 | 0.44% |
Vivo Capital, LLC | 530,991 | $7,800,000 | 0.35% |
Avoro Capital Advisors LLC | 1,468,318 | $21,570,000 | 0.34% |
Artal Group S.A. | 400,000 | $5,876,000 | 0.13% |
Rock Springs Capital Management LP | 334,050 | $4,907,000 | 0.10% |
Baker Brothers Advisors | 1,436,636 | $21,104,000 | 0.09% |
Eventide Asset Management | 400,000 | $5,876,000 | 0.08% |